V A Hryb
Index: Lik. Sprava (3-4) , 68-79, (2010)
Full Text: HTML
The complex open randomized clinical, instrumental and biochemical research with including 89 patients with type 2 diabetes mellitus (DM), complicated with distal symmetric polyneuropathy (DDSP) has been conducted. It is proved that the antioxidant "cocktail" application (Dialipon, Byocerulin, hepatoprotector with the antioxidant action Glutargin) contributes to the improvement of different levels of antioxidant defence, reduces free radical processes intensification, improves hepatocyte state which dysfunction is one of leading links of DDSP pathogenesis. These improves indirectly and directly the peripheral nerves functional state according electroneuromyography results, prevents DDSP progression and development of diabetic foot syndrome. Taking into account negative influence of Dialipon on the clinical parameters of DDSP with parallel intensification of free radical processes at decompensated DM in the early terms of treatment, Dialipon use is recommended after normalization of glycemia. At the same time the positive influence of Byocerulin has been noted regardless the compensation state of diabetes.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
L-Arginine L-glutamate
CAS:4320-30-3 |
C11H23N5O6 |
Arginine glutamate improves healing of radiation-induced ski...
2013-12-01 [Int. J. Radiat. Biol. 89(12) , 1108-15, (2013)] |
Effect of biotin on ammonia intoxication in rats and mice.
1995-06-01 [J. Gastroenterol. 30(3) , 351-5, (1995)] |
Circular dichroism and ultraviolet resonance Raman indicate ...
2011-04-14 [J. Phys. Chem. B 115(14) , 4234-43, (2011)] |
[Effect of a complex treatment, including glutargin and erbi...
2008-01-01 [Lik. Sprava (3-4) , 49-56, (2008)] |
[Changes in indices of connective tissue in patients with al...
2004-01-01 [Lik. Sprava (7) , 25-8, (2004)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved